Clinical effectiveness of Unani drugs in comparison to conventional drug in the treatment of dyslipidaemia (abnormal amount of fat in the blood)
- Conditions
- Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecified
- Registration Number
- CTRI/2019/05/019066
- Lead Sponsor
- Central Research Institute of Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Participants of any sex aged 30-60 years.
Participants with having following lipid or lipoprotein abnormality
in blood-
- Serum Cholesterol equal to or more than 200mg/dl.
- HDL-C less than 40 mg/dl
- LDL Cholesterol equal to or more than 130 mg/dl.
- Serum Triglycerides level equal to or more than
150mg/dl.
Both obese and non-obese.
Participants aged less than 30 and more than 60 years.
Participants having a co-morbid condition like IHD, HT, Diabetes, etc.
Participants having a major systemic disorder which interferes in the
present study.
Pregnant or Lactating Women.
Significant Pulmonary/Cardiovascular/Hepato-renal Dysfunction
Known cases of Immunocompromised states (HIV/ AIDS,
etc.)/Malignancies
Participant not willing to attend treatment schedule regularly
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Biochemical assessment of the change in Lipid and Lipoprotein levelTimepoint: At baseline, 2nd, 3rd and 4th followups
- Secondary Outcome Measures
Name Time Method Hemogram LFT, RFT, FPG, ECG and Urine R/M examinationTimepoint: At baseline, 3rd followup and after treatment, except ECG that will be at baseline and after treatment